Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1999
08/26/1999WO1999042610A1 METHODS FOR CHARACTERISING mRNA MOLECULES
08/26/1999WO1999042609A1 Detection of wheat and barley fungal pathogens using the polymerase chain reaction
08/26/1999WO1999042606A1 Methods of screening agents for activity using teleosts
08/26/1999WO1999042605A1 One dimensional chemical compound arrays and methods for assaying them
08/26/1999WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR
08/26/1999WO1999042600A1 Compositions and methods for modification of the gravitropic response of plants
08/26/1999WO1999042599A1 Isolated and purified nucleic acids comprising a gene specifically expressed in hop glands
08/26/1999WO1999042598A2 Hybrid seed production
08/26/1999WO1999042597A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
08/26/1999WO1999042596A2 Phosphodiesterase 10
08/26/1999WO1999042595A1 Mismatch cleavage enzymes from extreme thermophiles and uses thereof
08/26/1999WO1999042594A1 Fungus and insect control with chitinolytic enzymes
08/26/1999WO1999042593A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999WO1999042592A1 Methods for designing inhibitors of serine/threonine kinases and tyrosine kinases
08/26/1999WO1999042591A1 Method for producing biotin
08/26/1999WO1999042590A1 Method for producing trifluoro-3(r)-hydroxybutyric acid derivatives
08/26/1999WO1999042589A2 Insecticidal toxins from photorhabdus
08/26/1999WO1999042588A2 Group b streptococcus antigens
08/26/1999WO1999042587A1 Pollen specific promoter
08/26/1999WO1999042586A2 Exo1 and exo2, exocytotic proteins
08/26/1999WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
08/26/1999WO1999042584A1 Apoptosis inducing molecule ii and methods of use
08/26/1999WO1999042583A1 Connective tissue growth factor homologs
08/26/1999WO1999042582A1 Ammaid, a g protein coupled receptor
08/26/1999WO1999042581A1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3)
08/26/1999WO1999042580A2 Gaba receptors and their uses
08/26/1999WO1999042579A2 Caf1-related protein
08/26/1999WO1999042578A2 Modulation of cell proliferation, methods and reagents
08/26/1999WO1999042577A2 Biotin-binding receptor molecules
08/26/1999WO1999042576A1 Cerebellin-2 related polypeptides and dna coding therefor
08/26/1999WO1999042575A2 Calcium-activated potassium channel beta subunit gene and protein
08/26/1999WO1999042574A1 Sequences of an ih ionic channel and the use thereof
08/26/1999WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999WO1999042572A1 Candida boidinii dihydroxyacetone synthase promoter
08/26/1999WO1999042571A1 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1
08/26/1999WO1999042569A1 High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm
08/26/1999WO1999042567A1 Alkaline bacillus amylase
08/26/1999WO1999042566A1 Lipase variant
08/26/1999WO1999042565A1 Herbicides test method
08/26/1999WO1999042562A1 NOVEL pgsA
08/26/1999WO1999042485A1 Mucilage, a g-protein-coupled receptor
08/26/1999WO1999042484A1 Fishboy, a g-protein coupled receptor
08/26/1999WO1999042478A2 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32
08/26/1999WO1999042477A2 Transporter protein for saccharide-coupled medicaments
08/26/1999WO1999042474A2 Method for designing dna-binding proteins of the zinc-finger class
08/26/1999WO1999042472A1 Heat shock fusion-based vaccine system
08/26/1999WO1999042470A1 Secreted proteins and polynucleotides encoding them
08/26/1999WO1999042138A1 The use of bjerknes forces to manipulate contrast agents
08/26/1999WO1999042137A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
08/26/1999WO1999042133A1 Inhibitors of complement activation
08/26/1999WO1999042129A1 Purified sperm surface antigen, monoclonal antibody therefor and application therefor
08/26/1999WO1999042128A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999WO1999042127A2 Receptor derived peptides as modulators of receptor activity
08/26/1999WO1999042121A1 Modified heat shock protein-antigenic peptide complex
08/26/1999WO1999042118A2 Compounds and methods for diagnosis of tuberculosis
08/26/1999WO1999042091A2 Use of polycations as endosomolytic agents
08/26/1999WO1999042090A2 Treating cancer
08/26/1999WO1999042077A2 Compositions and methods for regulating lymphocyte activation
08/26/1999WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999WO1999042075A2 Antibodies against human cd40
08/26/1999WO1999041985A1 P53-dependent secretion of growth inhibitory factors
08/26/1999WO1999041984A1 INTERACTION BETWEEN THE MEC1-DEPENDENT DNA SYNTHESIS CHECKPOINT AND G1 CYCLIN FUNCTION IN $i(SACCAROMYCES CEREVISIAE)
08/26/1999WO1999041978A1 Performance enhancement
08/26/1999WO1999041974A1 Methods for improving seeds
08/26/1999WO1999033989A3 Rantes mutants and therapeutic applications thereof
08/26/1999WO1999032628A3 Wip, a wasp-associated protein
08/26/1999WO1999032606A3 Neural precursor cells, method for the production and use thereof in neural defect therapy
08/26/1999WO1999031257A3 Protein expression in baculovirus vector expression systems
08/26/1999WO1999031229A3 Peptides and nucleic acids derived from eisenia foetida and the use thereof
08/26/1999WO1999031136A3 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
08/26/1999WO1999029906A3 Gene family with transformation modulating activity
08/26/1999WO1999029905A3 Method for detecting apoptosis using fret labeled oligonucleotides
08/26/1999WO1999029883A3 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease
08/26/1999WO1999029844A3 Novel retroelements zam and idemfix, and their integrase
08/26/1999WO1999029732A3 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
08/26/1999WO1999029720A3 Mammalian alpha helical protein-1
08/26/1999WO1999029703A3 Isolation of nucleic acids
08/26/1999WO1999029159B1 Plant senescence-associated genes
08/26/1999WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/26/1999WO1999028342A3 Low-voltage activated calcium channel compositions and methods
08/26/1999WO1999027094A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
08/26/1999WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/26/1999WO1999021965A3 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto
08/26/1999WO1999020774A3 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
08/26/1999WO1999020769A3 Multiply-substituted protease variants
08/26/1999WO1999006428A9 Tango-72 and tango-77 nucleic acid molecules and polypeptides
08/26/1999WO1999004265A3 Cancer associated nucleic acids and polypeptides
08/26/1999WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999WO1998004693A3 Secreted proteins and polynucleotides encoding them
08/26/1999DE19907493A1 Recombinant nucleic acid encoding modified forms of peptides involved in neurodegenerative diseases, useful for identifying potential therapeutic agents
08/26/1999DE19835633C1 Animal or human tumor cells which express immunoglobulins
08/26/1999DE19811326C1 Preparation of medicaments for the treatment of tumor diseases and for immuno-suppression
08/26/1999DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors
08/26/1999DE19807265A1 New adenoviral vector useful for gene therapy
08/26/1999DE19806872A1 Production of biotin by expressing S-adenosyl-methionine synthase and second biotin synthesis gene in host cells
08/26/1999CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999CA2322617A1 Compounds and methods for diagnosis of tuberculosis
08/26/1999CA2322200A1 Receptor derived peptides as modulators of receptor activity
08/26/1999CA2322068A1 Methods for characterising mrna molecules
1 ... 3363 3364 3365 3366 3367 3368 3369 3370 3371 3372 3373 3374 3375 3376 3377 3378 3379 3380 3381 3382 3383 ... 4023